Harmine promotes megakaryocyte differentiation and thrombopoiesis by activating the Rac1/Cdc42/JNK pathway through a potential target of 5‐HTR2A

Harmine (HM), a β‐carboline alkaloid extracted from plants, is a crucial component of traditional Chinese medicine (TCM) known for its diverse pharmacological activities. Thrombocytopenia, a common and challenging hematological disorder, often coexists with serious illnesses. Previous research has s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Phytotherapy research 2024-11, Vol.38 (11), p.5134-5149
Hauptverfasser: Liu, Xiaoxi, Lai, Jia, Zhang, Xiaoqin, Wu, Anguo, Zhou, Ling, Li, Yueyue, Huang, Qianqian, Huang, Xinwu, Li, Hua, Lan, Cai, Liu, Jian, Huang, Feihong, Wu, Jianming
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 5149
container_issue 11
container_start_page 5134
container_title Phytotherapy research
container_volume 38
creator Liu, Xiaoxi
Lai, Jia
Zhang, Xiaoqin
Wu, Anguo
Zhou, Ling
Li, Yueyue
Huang, Qianqian
Huang, Xinwu
Li, Hua
Lan, Cai
Liu, Jian
Huang, Feihong
Wu, Jianming
description Harmine (HM), a β‐carboline alkaloid extracted from plants, is a crucial component of traditional Chinese medicine (TCM) known for its diverse pharmacological activities. Thrombocytopenia, a common and challenging hematological disorder, often coexists with serious illnesses. Previous research has shown a correlation between HM and thrombocytopenia, but the mechanism needs further elucidation. The aim of this study was to clarify the mechanisms underlying the effects of HM on thrombocytopenia and to develop new therapeutic strategies. Flow cytometry, Giemsa staining, and Phalloidin staining were used to assess HM's impact on Meg‐01 and HEL cell differentiation and maturation in vitro. A radiation‐induced thrombocytopenic mouse model was employed to evaluate HM's effect on platelet production in vivo. Network pharmacology, molecular docking, and protein blotting were utilized to investigate HM's targets and mechanisms. The results demonstrated that HM dose‐dependently promoted Meg‐01 and HEL cell differentiation and maturation in vitro and restored platelet levels in irradiated mice in vivo. Subsequently, HM was found to be involved in the biological process of platelet production by upregulating the expressions of Rac1, Cdc42, JNK, and 5‐HTR2A. Furthermore, the targeting of HM to 5‐HTR2A and its correlation with downstream Rac1/Cdc42/JNK were also confirmed. In conclusion, HM regulates megakaryocyte differentiation and thrombopoiesis through the 5‐HTR2A and Rac1/Cdc42/JNK pathways, providing a potential treatment strategy for thrombocytopenia. Schematic illustration of HM for MK differentiation and thrombopoiesis.
doi_str_mv 10.1002/ptr.8317
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3154163210</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3094044884</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2737-cca3daaafe5a97518fd1e20e64a1f7af68d606de0b61ce7b4b5ffa89e1d7be083</originalsourceid><addsrcrecordid>eNqFkcFu1DAQhi0EoktB4gmQJS5c0rUdJ3GO1QpYoAK0WiRu0cQZ77ps4mA7VLnxCIhH5EnwtgUkJMRpDvPNN5r5CXnM2RlnTCzH6M9Uzqs7ZMFZXWe8qPK7ZMHqgmeSq48n5EEIl4yxWjB5n5zkNS9EJcoF-b4G39sB6ehd7yIG2uMOPoGfnZ4j0s4agx6HaCFaN1AYOhr3iW3d6CwGG2g7U9DRfknAsEtNpBvQfLnqtBTL12_f0BHi_grm67lpt6dAx7TpqDzQCH6HkTpDix9fv623G3H-kNwzcAj46Laekg8vnm9X6-zi3ctXq_OLTIsqrzKtIe8AwGABdVVwZTqOgmEpgZsKTKm6kpUdsrbkGqtWtoUxoGrkXdUiU_kpeXbjTad_njDEprdB4-EAA7opNDkvJC9zwdn_UVZLJqVSMqFP_0Iv3eSHdEgSCsWYkmX9R6i9C8GjaUZv-_T1hrPmGGmTIm2OkSb0ya1wanvsfoO_MkxAdgNc2QPO_xQ177eba-FPXJGtVw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3128008469</pqid></control><display><type>article</type><title>Harmine promotes megakaryocyte differentiation and thrombopoiesis by activating the Rac1/Cdc42/JNK pathway through a potential target of 5‐HTR2A</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Liu, Xiaoxi ; Lai, Jia ; Zhang, Xiaoqin ; Wu, Anguo ; Zhou, Ling ; Li, Yueyue ; Huang, Qianqian ; Huang, Xinwu ; Li, Hua ; Lan, Cai ; Liu, Jian ; Huang, Feihong ; Wu, Jianming</creator><creatorcontrib>Liu, Xiaoxi ; Lai, Jia ; Zhang, Xiaoqin ; Wu, Anguo ; Zhou, Ling ; Li, Yueyue ; Huang, Qianqian ; Huang, Xinwu ; Li, Hua ; Lan, Cai ; Liu, Jian ; Huang, Feihong ; Wu, Jianming</creatorcontrib><description>Harmine (HM), a β‐carboline alkaloid extracted from plants, is a crucial component of traditional Chinese medicine (TCM) known for its diverse pharmacological activities. Thrombocytopenia, a common and challenging hematological disorder, often coexists with serious illnesses. Previous research has shown a correlation between HM and thrombocytopenia, but the mechanism needs further elucidation. The aim of this study was to clarify the mechanisms underlying the effects of HM on thrombocytopenia and to develop new therapeutic strategies. Flow cytometry, Giemsa staining, and Phalloidin staining were used to assess HM's impact on Meg‐01 and HEL cell differentiation and maturation in vitro. A radiation‐induced thrombocytopenic mouse model was employed to evaluate HM's effect on platelet production in vivo. Network pharmacology, molecular docking, and protein blotting were utilized to investigate HM's targets and mechanisms. The results demonstrated that HM dose‐dependently promoted Meg‐01 and HEL cell differentiation and maturation in vitro and restored platelet levels in irradiated mice in vivo. Subsequently, HM was found to be involved in the biological process of platelet production by upregulating the expressions of Rac1, Cdc42, JNK, and 5‐HTR2A. Furthermore, the targeting of HM to 5‐HTR2A and its correlation with downstream Rac1/Cdc42/JNK were also confirmed. In conclusion, HM regulates megakaryocyte differentiation and thrombopoiesis through the 5‐HTR2A and Rac1/Cdc42/JNK pathways, providing a potential treatment strategy for thrombocytopenia. Schematic illustration of HM for MK differentiation and thrombopoiesis.</description><identifier>ISSN: 0951-418X</identifier><identifier>ISSN: 1099-1573</identifier><identifier>EISSN: 1099-1573</identifier><identifier>DOI: 10.1002/ptr.8317</identifier><identifier>PMID: 39152726</identifier><language>eng</language><publisher>Chichester, UK: John Wiley &amp; Sons, Ltd</publisher><subject>5‐HTR2A/Rac1/Cdc42/JNK ; alkaloids ; Animals ; Biological activity ; Blood Platelets - drug effects ; Cdc42 protein ; Cell differentiation ; Cell Differentiation - drug effects ; Differentiation (biology) ; Flow cytometry ; harmine ; Harmine - pharmacology ; Hematological diseases ; Herbal medicine ; Humans ; In vivo methods and tests ; irradiation ; Male ; MAP Kinase Signaling System - drug effects ; Maturation ; Medicinal plants ; megakaryocyte differentiation ; Megakaryocytes - drug effects ; Mice ; Molecular docking ; Molecular Docking Simulation ; Oriental traditional medicine ; Phalloidin ; phalloidine ; Pharmacology ; phytotherapy ; Plant extracts ; Plant layout ; Platelets ; rac1 GTP-Binding Protein - metabolism ; Rac1 protein ; radiation ; Receptor, Serotonin, 5-HT2A - metabolism ; Staining ; Thrombocytopenia ; Thrombocytopenia - drug therapy ; Thrombopoiesis ; Thrombopoiesis - drug effects ; Traditional Chinese medicine</subject><ispartof>Phytotherapy research, 2024-11, Vol.38 (11), p.5134-5149</ispartof><rights>2024 John Wiley &amp; Sons Ltd.</rights><rights>2024 John Wiley &amp; Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2737-cca3daaafe5a97518fd1e20e64a1f7af68d606de0b61ce7b4b5ffa89e1d7be083</cites><orcidid>0000-0003-4688-6081 ; 0000-0002-6136-7469</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fptr.8317$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fptr.8317$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39152726$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Xiaoxi</creatorcontrib><creatorcontrib>Lai, Jia</creatorcontrib><creatorcontrib>Zhang, Xiaoqin</creatorcontrib><creatorcontrib>Wu, Anguo</creatorcontrib><creatorcontrib>Zhou, Ling</creatorcontrib><creatorcontrib>Li, Yueyue</creatorcontrib><creatorcontrib>Huang, Qianqian</creatorcontrib><creatorcontrib>Huang, Xinwu</creatorcontrib><creatorcontrib>Li, Hua</creatorcontrib><creatorcontrib>Lan, Cai</creatorcontrib><creatorcontrib>Liu, Jian</creatorcontrib><creatorcontrib>Huang, Feihong</creatorcontrib><creatorcontrib>Wu, Jianming</creatorcontrib><title>Harmine promotes megakaryocyte differentiation and thrombopoiesis by activating the Rac1/Cdc42/JNK pathway through a potential target of 5‐HTR2A</title><title>Phytotherapy research</title><addtitle>Phytother Res</addtitle><description>Harmine (HM), a β‐carboline alkaloid extracted from plants, is a crucial component of traditional Chinese medicine (TCM) known for its diverse pharmacological activities. Thrombocytopenia, a common and challenging hematological disorder, often coexists with serious illnesses. Previous research has shown a correlation between HM and thrombocytopenia, but the mechanism needs further elucidation. The aim of this study was to clarify the mechanisms underlying the effects of HM on thrombocytopenia and to develop new therapeutic strategies. Flow cytometry, Giemsa staining, and Phalloidin staining were used to assess HM's impact on Meg‐01 and HEL cell differentiation and maturation in vitro. A radiation‐induced thrombocytopenic mouse model was employed to evaluate HM's effect on platelet production in vivo. Network pharmacology, molecular docking, and protein blotting were utilized to investigate HM's targets and mechanisms. The results demonstrated that HM dose‐dependently promoted Meg‐01 and HEL cell differentiation and maturation in vitro and restored platelet levels in irradiated mice in vivo. Subsequently, HM was found to be involved in the biological process of platelet production by upregulating the expressions of Rac1, Cdc42, JNK, and 5‐HTR2A. Furthermore, the targeting of HM to 5‐HTR2A and its correlation with downstream Rac1/Cdc42/JNK were also confirmed. In conclusion, HM regulates megakaryocyte differentiation and thrombopoiesis through the 5‐HTR2A and Rac1/Cdc42/JNK pathways, providing a potential treatment strategy for thrombocytopenia. Schematic illustration of HM for MK differentiation and thrombopoiesis.</description><subject>5‐HTR2A/Rac1/Cdc42/JNK</subject><subject>alkaloids</subject><subject>Animals</subject><subject>Biological activity</subject><subject>Blood Platelets - drug effects</subject><subject>Cdc42 protein</subject><subject>Cell differentiation</subject><subject>Cell Differentiation - drug effects</subject><subject>Differentiation (biology)</subject><subject>Flow cytometry</subject><subject>harmine</subject><subject>Harmine - pharmacology</subject><subject>Hematological diseases</subject><subject>Herbal medicine</subject><subject>Humans</subject><subject>In vivo methods and tests</subject><subject>irradiation</subject><subject>Male</subject><subject>MAP Kinase Signaling System - drug effects</subject><subject>Maturation</subject><subject>Medicinal plants</subject><subject>megakaryocyte differentiation</subject><subject>Megakaryocytes - drug effects</subject><subject>Mice</subject><subject>Molecular docking</subject><subject>Molecular Docking Simulation</subject><subject>Oriental traditional medicine</subject><subject>Phalloidin</subject><subject>phalloidine</subject><subject>Pharmacology</subject><subject>phytotherapy</subject><subject>Plant extracts</subject><subject>Plant layout</subject><subject>Platelets</subject><subject>rac1 GTP-Binding Protein - metabolism</subject><subject>Rac1 protein</subject><subject>radiation</subject><subject>Receptor, Serotonin, 5-HT2A - metabolism</subject><subject>Staining</subject><subject>Thrombocytopenia</subject><subject>Thrombocytopenia - drug therapy</subject><subject>Thrombopoiesis</subject><subject>Thrombopoiesis - drug effects</subject><subject>Traditional Chinese medicine</subject><issn>0951-418X</issn><issn>1099-1573</issn><issn>1099-1573</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFu1DAQhi0EoktB4gmQJS5c0rUdJ3GO1QpYoAK0WiRu0cQZ77ps4mA7VLnxCIhH5EnwtgUkJMRpDvPNN5r5CXnM2RlnTCzH6M9Uzqs7ZMFZXWe8qPK7ZMHqgmeSq48n5EEIl4yxWjB5n5zkNS9EJcoF-b4G39sB6ehd7yIG2uMOPoGfnZ4j0s4agx6HaCFaN1AYOhr3iW3d6CwGG2g7U9DRfknAsEtNpBvQfLnqtBTL12_f0BHi_grm67lpt6dAx7TpqDzQCH6HkTpDix9fv623G3H-kNwzcAj46Laekg8vnm9X6-zi3ctXq_OLTIsqrzKtIe8AwGABdVVwZTqOgmEpgZsKTKm6kpUdsrbkGqtWtoUxoGrkXdUiU_kpeXbjTad_njDEprdB4-EAA7opNDkvJC9zwdn_UVZLJqVSMqFP_0Iv3eSHdEgSCsWYkmX9R6i9C8GjaUZv-_T1hrPmGGmTIm2OkSb0ya1wanvsfoO_MkxAdgNc2QPO_xQ177eba-FPXJGtVw</recordid><startdate>202411</startdate><enddate>202411</enddate><creator>Liu, Xiaoxi</creator><creator>Lai, Jia</creator><creator>Zhang, Xiaoqin</creator><creator>Wu, Anguo</creator><creator>Zhou, Ling</creator><creator>Li, Yueyue</creator><creator>Huang, Qianqian</creator><creator>Huang, Xinwu</creator><creator>Li, Hua</creator><creator>Lan, Cai</creator><creator>Liu, Jian</creator><creator>Huang, Feihong</creator><creator>Wu, Jianming</creator><general>John Wiley &amp; Sons, Ltd</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope><orcidid>https://orcid.org/0000-0003-4688-6081</orcidid><orcidid>https://orcid.org/0000-0002-6136-7469</orcidid></search><sort><creationdate>202411</creationdate><title>Harmine promotes megakaryocyte differentiation and thrombopoiesis by activating the Rac1/Cdc42/JNK pathway through a potential target of 5‐HTR2A</title><author>Liu, Xiaoxi ; Lai, Jia ; Zhang, Xiaoqin ; Wu, Anguo ; Zhou, Ling ; Li, Yueyue ; Huang, Qianqian ; Huang, Xinwu ; Li, Hua ; Lan, Cai ; Liu, Jian ; Huang, Feihong ; Wu, Jianming</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2737-cca3daaafe5a97518fd1e20e64a1f7af68d606de0b61ce7b4b5ffa89e1d7be083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>5‐HTR2A/Rac1/Cdc42/JNK</topic><topic>alkaloids</topic><topic>Animals</topic><topic>Biological activity</topic><topic>Blood Platelets - drug effects</topic><topic>Cdc42 protein</topic><topic>Cell differentiation</topic><topic>Cell Differentiation - drug effects</topic><topic>Differentiation (biology)</topic><topic>Flow cytometry</topic><topic>harmine</topic><topic>Harmine - pharmacology</topic><topic>Hematological diseases</topic><topic>Herbal medicine</topic><topic>Humans</topic><topic>In vivo methods and tests</topic><topic>irradiation</topic><topic>Male</topic><topic>MAP Kinase Signaling System - drug effects</topic><topic>Maturation</topic><topic>Medicinal plants</topic><topic>megakaryocyte differentiation</topic><topic>Megakaryocytes - drug effects</topic><topic>Mice</topic><topic>Molecular docking</topic><topic>Molecular Docking Simulation</topic><topic>Oriental traditional medicine</topic><topic>Phalloidin</topic><topic>phalloidine</topic><topic>Pharmacology</topic><topic>phytotherapy</topic><topic>Plant extracts</topic><topic>Plant layout</topic><topic>Platelets</topic><topic>rac1 GTP-Binding Protein - metabolism</topic><topic>Rac1 protein</topic><topic>radiation</topic><topic>Receptor, Serotonin, 5-HT2A - metabolism</topic><topic>Staining</topic><topic>Thrombocytopenia</topic><topic>Thrombocytopenia - drug therapy</topic><topic>Thrombopoiesis</topic><topic>Thrombopoiesis - drug effects</topic><topic>Traditional Chinese medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Xiaoxi</creatorcontrib><creatorcontrib>Lai, Jia</creatorcontrib><creatorcontrib>Zhang, Xiaoqin</creatorcontrib><creatorcontrib>Wu, Anguo</creatorcontrib><creatorcontrib>Zhou, Ling</creatorcontrib><creatorcontrib>Li, Yueyue</creatorcontrib><creatorcontrib>Huang, Qianqian</creatorcontrib><creatorcontrib>Huang, Xinwu</creatorcontrib><creatorcontrib>Li, Hua</creatorcontrib><creatorcontrib>Lan, Cai</creatorcontrib><creatorcontrib>Liu, Jian</creatorcontrib><creatorcontrib>Huang, Feihong</creatorcontrib><creatorcontrib>Wu, Jianming</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><jtitle>Phytotherapy research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Xiaoxi</au><au>Lai, Jia</au><au>Zhang, Xiaoqin</au><au>Wu, Anguo</au><au>Zhou, Ling</au><au>Li, Yueyue</au><au>Huang, Qianqian</au><au>Huang, Xinwu</au><au>Li, Hua</au><au>Lan, Cai</au><au>Liu, Jian</au><au>Huang, Feihong</au><au>Wu, Jianming</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Harmine promotes megakaryocyte differentiation and thrombopoiesis by activating the Rac1/Cdc42/JNK pathway through a potential target of 5‐HTR2A</atitle><jtitle>Phytotherapy research</jtitle><addtitle>Phytother Res</addtitle><date>2024-11</date><risdate>2024</risdate><volume>38</volume><issue>11</issue><spage>5134</spage><epage>5149</epage><pages>5134-5149</pages><issn>0951-418X</issn><issn>1099-1573</issn><eissn>1099-1573</eissn><abstract>Harmine (HM), a β‐carboline alkaloid extracted from plants, is a crucial component of traditional Chinese medicine (TCM) known for its diverse pharmacological activities. Thrombocytopenia, a common and challenging hematological disorder, often coexists with serious illnesses. Previous research has shown a correlation between HM and thrombocytopenia, but the mechanism needs further elucidation. The aim of this study was to clarify the mechanisms underlying the effects of HM on thrombocytopenia and to develop new therapeutic strategies. Flow cytometry, Giemsa staining, and Phalloidin staining were used to assess HM's impact on Meg‐01 and HEL cell differentiation and maturation in vitro. A radiation‐induced thrombocytopenic mouse model was employed to evaluate HM's effect on platelet production in vivo. Network pharmacology, molecular docking, and protein blotting were utilized to investigate HM's targets and mechanisms. The results demonstrated that HM dose‐dependently promoted Meg‐01 and HEL cell differentiation and maturation in vitro and restored platelet levels in irradiated mice in vivo. Subsequently, HM was found to be involved in the biological process of platelet production by upregulating the expressions of Rac1, Cdc42, JNK, and 5‐HTR2A. Furthermore, the targeting of HM to 5‐HTR2A and its correlation with downstream Rac1/Cdc42/JNK were also confirmed. In conclusion, HM regulates megakaryocyte differentiation and thrombopoiesis through the 5‐HTR2A and Rac1/Cdc42/JNK pathways, providing a potential treatment strategy for thrombocytopenia. Schematic illustration of HM for MK differentiation and thrombopoiesis.</abstract><cop>Chichester, UK</cop><pub>John Wiley &amp; Sons, Ltd</pub><pmid>39152726</pmid><doi>10.1002/ptr.8317</doi><tpages>16</tpages><orcidid>https://orcid.org/0000-0003-4688-6081</orcidid><orcidid>https://orcid.org/0000-0002-6136-7469</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0951-418X
ispartof Phytotherapy research, 2024-11, Vol.38 (11), p.5134-5149
issn 0951-418X
1099-1573
1099-1573
language eng
recordid cdi_proquest_miscellaneous_3154163210
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects 5‐HTR2A/Rac1/Cdc42/JNK
alkaloids
Animals
Biological activity
Blood Platelets - drug effects
Cdc42 protein
Cell differentiation
Cell Differentiation - drug effects
Differentiation (biology)
Flow cytometry
harmine
Harmine - pharmacology
Hematological diseases
Herbal medicine
Humans
In vivo methods and tests
irradiation
Male
MAP Kinase Signaling System - drug effects
Maturation
Medicinal plants
megakaryocyte differentiation
Megakaryocytes - drug effects
Mice
Molecular docking
Molecular Docking Simulation
Oriental traditional medicine
Phalloidin
phalloidine
Pharmacology
phytotherapy
Plant extracts
Plant layout
Platelets
rac1 GTP-Binding Protein - metabolism
Rac1 protein
radiation
Receptor, Serotonin, 5-HT2A - metabolism
Staining
Thrombocytopenia
Thrombocytopenia - drug therapy
Thrombopoiesis
Thrombopoiesis - drug effects
Traditional Chinese medicine
title Harmine promotes megakaryocyte differentiation and thrombopoiesis by activating the Rac1/Cdc42/JNK pathway through a potential target of 5‐HTR2A
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T00%3A51%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Harmine%20promotes%20megakaryocyte%20differentiation%20and%20thrombopoiesis%20by%20activating%20the%20Rac1/Cdc42/JNK%20pathway%20through%20a%20potential%20target%20of%205%E2%80%90HTR2A&rft.jtitle=Phytotherapy%20research&rft.au=Liu,%20Xiaoxi&rft.date=2024-11&rft.volume=38&rft.issue=11&rft.spage=5134&rft.epage=5149&rft.pages=5134-5149&rft.issn=0951-418X&rft.eissn=1099-1573&rft_id=info:doi/10.1002/ptr.8317&rft_dat=%3Cproquest_cross%3E3094044884%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3128008469&rft_id=info:pmid/39152726&rfr_iscdi=true